Organization

Genecast Biotechnology Co., Ltd, Beijing, China

2 abstracts

Abstract
Identification of prognostic tumor microenvironment in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy in combination with lenvatinib and PD-1 inhibitors.
Org: The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, Department of Minimally Invasive Interventional Therapy, Sun Yat-sen University Cancer Center, Sun Yat-sen University State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China, Genecast Biotechnology Co., Ltd, Beijing, China,